Jeff Jonas joins Shire leadership team

Tuesday, November 20, 2012 11:51 AM

Irish specialty biopharmaceutical company Shire has appointed Jeff Jonas, MD, as president of Shire's regenerative medicine business.

After a varied career in R&D, commercial and entrepreneurial business roles, Jonas joined Shire in July 2008 as leader of the specialty pharmaceuticals R&D team. He has been closely involved with the regenerative medicine business since Shire acquired it as Advanced BioHealing in June 2011. In addition to his role as head of the specialty pharmaceuticals R&D team, Jonas has been leading the regenerative medicine R&D team and has been a member of the leadership team.

Before joining Shire in 2008, Jonas served as executive vice president at Isis Pharmaceuticals and before that, as chief medical officer and executive vice president at Forest Laboratories. Jonas began his career at Upjohn Laboratories where he advanced to the position of chief medical officer.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs